Boji Medical Technology Co.,Ltd. (SHE:300404)
China
· Delayed Price · Currency is CNY 10.59
-0.03 (-0.28%)
At close: Apr 29, 2026
Boji Medical Technology Revenue
Boji Medical Technology had revenue of 220.16M CNY in the quarter ending March 31, 2026, with 58.54% growth. This brings the company's revenue in the last twelve months to 949.94M, up 33.15% year-over-year. In the year 2025, Boji Medical Technology had annual revenue of 868.64M with 17.06% growth.
Revenue (ttm)
949.94M
Revenue Growth
+33.15%
P/S Ratio
4.27
Revenue / Employee
788.33K
Employees
1,205
Market Cap
4.06B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 868.64M | 126.62M | 17.06% |
| Dec 31, 2024 | 742.02M | 186.19M | 33.50% |
| Dec 31, 2023 | 555.83M | 132.15M | 31.19% |
| Jan 1, 2023 | 423.68M | 99.48M | 30.68% |
| Jan 1, 2022 | 324.20M | 63.73M | 24.47% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Baolingbao Biology | 2.81B |
| Guanhao Biotech | 387.75M |
| Shanghai Serum Bio-Technology | 197.68M |
| Qingdao Vland Biotech INC. | 1.37B |
| Zhejiang Wecome Pharmaceutical Company | 131.67M |
| Shanghai Obio Technology (Group) Corp. | 267.70M |
| Zhejiang Shouxiangu Pharmaceutical | 642.66M |
| Pulike Biological Engineering | 1.10B |